Topic: biotech funding

Sort by: Relevance | Date
  • Craif Secures $22M to Advance Early Cancer Detection Tech
    April 28, 2025
    90%

    Craif Secures $22M to Advance Early Cancer Detection Tech

    Craif, a Japanese biotech startup, secured $22 million in Series C funding to expand its urine-based cancer detection technology into the U.S. market, addressing the limitations of current invasive screening methods. The company’s miSignal platform, utilizing microRNA biomarkers in urine, has alr...

    Read More »
  • Aerska's $39M Boost Targets Brain-Delivery for RNA Medicines
    February 11, 2026
    65%

    Aerska's $39M Boost Targets Brain-Delivery for RNA Medicines

    Aerska, a Dublin biotech firm, has secured $39 million to develop a delivery system that can transport advanced genetic medicines across the protective blood-brain barrier to treat neurodegenerative diseases. The company's technology aims to use RNA interference to target and reduce the productio...

    Read More »

Related Topics

craifs product misignal (1) preclinical development (1) early cancer detection (1) subscription models health screening (1) craifs series c funding (1) neurodegenerative disease applications (1) urine-based testing technology (1) neurodegenerative disease (1)